|
Virtual Patient: Adult Male with Reaction to Yellow Jacket Sting
This course contains a case simulation with a patient who has had a severe reaction to a yellow jacket sting. The learner will receive the patient history, and based on test results, choose the best way to treat the patient with immunotherapy. The learner will answer specific questions that explain the immunotherapy treatment, including benefits, risks, intervals, duration, and possibility of relapse to the patient. The learner will receive feedback for each decision that is made, and numerous... |
|
|
Challenges in Patient Safety in Psychiatry
Patients with mental illness are at higher risk for adverse events including suicide, lack of medication adherence, and less likely to seek help during relapse. As pressure to discharge increases in addition to treatment plans, patients with mental illness must also have a safety plan beyond the length of hospitalization that makes the patient an equal participant and involves their entire care team, including family members.
In this CME Outfitters Snack, expert faculty will discuss safety... |
|
|
But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents
The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT... |
|
|
But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents
The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT... |
|
|
Treatment Decision Making and Achieving Therapeutic Goals in Multiple Sclerosis: Individual and Systems-Level Advances: Evaluation and Management of Suboptimal Treatment Response
Since the advent of the first treatment for relapsing-remitting multiple sclerosis more than 2 decades ago, considerable changes have altered management approaches. In recent decades, the goals of treatment for MS have generally shifted from reducing the frequency and severity of relapses and delaying progression to preventing new or enhancing lesions on magnetic resonance imaging and reducing brain atrophy. Healthcare providers increasingly rely on coordination of care and systems-based strat... |
|
|
But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents
The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT... |
|
|
Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?
Long-acting injectable (LAI) antipsychotics can prevent relapses and hospitalizations, but they are underutilized, especially early in the course of illness. Health care providers need confidence in discussing LAIs with patients. LAI antipsychotics may be a reasonable option for many patients with schizophrenia and should be discussed routinely when evaluating treatment options. Health care providers may lack knowledge of options for LAI antipsychotics and be reluctant to discuss this therapy,... |
|
|
But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents
The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT... |
|
|
But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents
The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT... |
|
|
But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents
The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT... |
|
|
But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents
The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT... |
|
|
Multiple Myeloma Expert Roundtable: Stem Cell Transplantation, Maintenance Therapy, and Relapsed/Refractory Disease
With numerous recent advances in available treatments and options for diagnosis and staging, disease monitoring, and supportive care, the outlook for patients with multiple myeloma has never been brighter. However, this expansion of clinical options has also introduced potentially daunting challenges for the health care providers charged with the care of these patients.
This activity presents a robust roundtable discussion in which our expert faculty provides insights on such issues as dete... |
|
|
Effective Treatment for Complex PTSD Related to Childhood Abuse and Multiple Traumatization
This workshop will present a flexibly-applied, evidence-based 16 session treatment for adults who have complex forms of PTSD related to childhood abuse and multiple life traumas. This sequential, two-phase treatment is based in a developmental model which is sensitive to the disturbances in attachment, emotion regulation and interpersonal functioning that survivors of childhood or chronic interpersonal violence often bring to treatment. Phase 1: Skills Training in Affective and Interpersonal. ... |
|
|
But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents
The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT... |
|
|
Integrating Therapeutic Advances to Improve Current Practices in Myeloma Patient Care
Improving outcomes for patients with multiple myeloma requires building on the foundation of current therapies with new agents and combinations, recognizing the nature of each individual patient’s disease, and providing a personalized approach to treatment. This activity uses evidence-based presentations and case study vignettes to present the latest information on selecting the most appropriate therapy based on patient profile, clinical evidence, and assessment of risk-versus-benefit.
Le... |
|
|
Evidence-based Updates in Non-Hodgkin’s Lymphoma
Significant advances in treatment with novel agents for B-cell non-Hodgkin’s lymphoma (NHL) have improved patient outcomes and survival. However, many patients are at high-risk of relapse, meriting a precision approach to reduce the rate of recurrence and improve outcomes. The identification of molecular subtypes, the persistence of clinical challenges, and the anticipated emergence of clinical data necessitate a collaborative treatment approach to ensure individualized care for patients wit... |
|
|
Navigating New Options to Improve Outcomes in Multiple Myeloma
As new combinations and classes of agents emerge for the treatment of multiple myeloma (MM), community-based treatment teams require clarity on the optimal integration of recently approved and emerging agents into the relapsed/refractory landscape for MM. While high-dose chemotherapy is not appropriate for all patients, multiple options have emerged that demonstrate a clinical benefit and require proper integration into the treatment paradigm. In addition, clinicians must meet requirements for... |
|
|
Finding Feeling: Treating Traumatic Dissociation
Trauma is a both a physical and psychological disruption, a discontinuity in experience. The helplessness associated with it challenges a person’s sense of agency and therefore their customary control over mind and body. Dissociative disorders constitute a failure of integration of identity, memory, or consciousness, andmost often occur in the aftermath of trauma. A Dissociative Subtype has been added to the diagnosis of Post-Traumatic Stress Disorder the DSM-5. This requires all of the DSM-... |
|
|
A 4-Year Prospective Study of Eating Disorder NOS
To examine the course of Eating Disorder NOS (EDNOS) compared with anorexia nervosa (AN), bulimia nervosa (BN) and binge eating disorder (BED). Method: Prospective study of 385 participants meeting DSM-IV criteria for AN, BN, BED and EDNOS at 3 sites. Recruitment was from the community and specialty clinics. Participants were followed at 6-month intervals over a 4-year period using the Eating Disorder Examination as the primary assessment. Results: EDNOS remitted significantly more quickly tha... |
|
|
Separation Anxiety in Children & Adolescents
This CE test is based on the book "Separation Anxiety in Children & Adolescents" (2005, 298 pages). The book presents a research-based approach to understanding the challenges of separation anxiety and helping children, adolescents, and their parents build the skills they need to overcome it. The authors provide step-by-step guidelines for implementing the entire process of therapy-from intake and assessment through coping skills training, cognitive-behavioral interventions, and relapse preven... |
|
|
Substance Abuse and Dependency
Target audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors
This course looks at the assessment and treatment of a variety of drug and alcohol related issues as well as an in-depth look at the behavioral and physiological effects of some of the most commonly abused drugs.
Reading of the books, "Treating Alcohol and Drug Problems in Psychotherapy Practice" and "Buzzed: The Straight Facts about the Most Used and Abused Drugs from Alcohol t... |
|
|
Substance Abuse Treatment: Addressing the Specific Needs of Women
Target Audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors
Course Syllabus:
* Introduction
* Patterns of Use: From Initiation to Treatment
* Substance Use and Birth Outcomes
* Culturally Responsive Screening and Assessment
* The Impact of Trauma and Prenatal Care
* Substance Abuse Among Specific Population Groups
* Relational Model Approach
* Postpartum Relapse Prevention |
|
|
Tobacco use and mental illness
Overview of contributing factors to the increased use of tobacco amongst individuals with mental illness.
Target audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors
Syllabus:
* Tobacco use & mental illness
* Assessment & intervention
* Smoking cessation
* Relapse prevention
Unlimited Access to Over 200 Courses
Starting at Only $74.99 |
|
|
Introduction and Overview (Section I); and The Older Adult Treatment Population (Section II): From Substance Abuse Relapse Prevention for Older Adults--A Group Treatment Approach
I. Introduction and Overview: From Substance Abuse Relapse Prevention for Older Adults—A Group Treatment Approach provides background and how-to directions for introducing relapse techniques to older clients.
II. The Older Adult Treatment Population: From Substance Abuse Relapse Prevention for Older Adults—A Group Treatment Approach provides an overview of the target population for cognitive-behavioral and self-management intervention (CB/SM) for older adults who have substance use diso... |
|
|
Codependency: Causes, Consequences and Cures
In this course, the author offers in-depth and in-person strategies for therapists to use in working with clients who present with the characteristic behavior patterns of codependency. Clients are usually unaware of the underlying codependency that is often responsible for the symptoms they’re suffering. Starting with emphasis on the delicate process of building a caring therapeutic relationship with these clients, the author guides readers through the early shame-inducing parenting styles t... |
|